[13C2,2H6]-Dabrafenib carboxylate dilithium salt
| Catalog Number |
ACMA00065542 |
| Description |
Dabrafenib carboxylate dilithium salt is intended for Pharmaceuticals applications. It is a metabolite of Dabrefenib which is used in the treatment of melanoma associated with a mutated version of the gene BRAF. All information about [13C2,2H6]-Dabrafenib carboxylate dilithium salt is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Molecular Weight |
569.43 |
| Molecular Formula |
C23H16F3N5O4S2·2Li |
| Purity |
≥98% |
| Isotopic Enrichment |
99% 13C, 98% 2H |
| Stability |
≥1 year |
| Unlabeled CAS |
Free acid: 1195873-54-1 |
Please kindly note that our products and services are for research use only.
